Evidence-gap map · non-drug interventions

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome evidence gaps

63 registered non-drug trials, mapped by approach and outcome.

  1. Research Tracker
  2. Evidence-gap maps
  3. Myalgic Encephalomyelitis / Chronic Fatigue Syndrome

Which non-drug approaches have been tested for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome, and which outcomes they were tested on. An empty cell means no matching trial was found among those searched: a possible gap, not proof that nobody has asked the question.

63registered non-drug trials
3with results posted
13recruiting as of 2026-11-16
64group × outcome cells with at least one trial
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Evidence-gap matrix

Each number is the count of trials; "with results" is how many of them have posted results on ClinicalTrials.gov. A trial is counted once per group and per outcome domain it covers. The number in brackets after each group is its total trials for this condition.

none1–23–910–2930 or more
Registered non-drug trials for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome by intervention group and primary outcome domain
Intervention groupFatigue and energyPost-exertional symptomsCognitionMood, anxiety and wellbeingPainSleepPhysical function and exercise capacityHeart rate, blood pressure and autonomicBreathing and lung functionQuality of lifeWeight and metabolic markersInflammation and other biomarkersSymptom severity and disease activityClinical events, survival and healthcare useFeasibility, adherence and safetyNot classified
Exercise and physical activity (10)4··12112···12·12
Rehabilitation and therapy services (5)41····31·1··1·1·
Breathing and respiratory training (2)11 with results·1·11 with results··1········
Mind-body and psychological approaches (8)4·11··4·····21 with results···
Cognitive training and education (3)··11··1··2···1··
Diet, fasting and nutrition (2)2···········2···
Neuromodulation and electrical stimulation (6)412·1·11 with results1·21 with results··111·
Oxygen, light, temperature and manual therapies (12)7·1·11·····13·2·
Supplements and nutraceuticals (12)5·1·3··1····1··1
Other devices and digital tools (1)·····1·1····1···
Other behavioural, not yet classified (9)2·1···31·2··31·1

The table scrolls sideways: 16 outcome columns.

No trials found for this condition in: Sleep and circadian approaches; Care delivery and health services.

Where the gaps are

Outcomes not found as a primary outcome in a group's trials

  • Among the 12 trials of oxygen, light, temperature and manual therapies found, none used physical function and exercise capacity as a primary outcome (11 trials of other approaches did).
  • Among the 12 trials of supplements and nutraceuticals found, none used physical function and exercise capacity as a primary outcome (11 trials of other approaches did).
  • Among the 8 trials of mind-body and psychological approaches found, none used pain as a primary outcome (8 trials of other approaches did).
  • Among the 12 trials of oxygen, light, temperature and manual therapies found, none used quality of life as a primary outcome (7 trials of other approaches did).
  • Among the 12 trials of supplements and nutraceuticals found, none used quality of life as a primary outcome (7 trials of other approaches did).
  • Among the 10 trials of exercise and physical activity found, none used quality of life as a primary outcome (7 trials of other approaches did).
  • Among the 8 trials of mind-body and psychological approaches found, none used quality of life as a primary outcome (7 trials of other approaches did).
  • Among the 12 trials of oxygen, light, temperature and manual therapies found, none used heart rate, blood pressure and autonomic as a primary outcome (6 trials of other approaches did).
  • Among the 8 trials of mind-body and psychological approaches found, none used heart rate, blood pressure and autonomic as a primary outcome (6 trials of other approaches did).
  • Among the 10 trials of exercise and physical activity found, none used cognition as a primary outcome (5 trials of other approaches did).
  • Among the 12 trials of oxygen, light, temperature and manual therapies found, none used mood, anxiety and wellbeing as a primary outcome (3 trials of other approaches did).
  • Among the 12 trials of supplements and nutraceuticals found, none used mood, anxiety and wellbeing as a primary outcome (3 trials of other approaches did).
  • Among the 12 trials of supplements and nutraceuticals found, none used sleep as a primary outcome (3 trials of other approaches did).
  • Among the 8 trials of mind-body and psychological approaches found, none used sleep as a primary outcome (3 trials of other approaches did).

Questions studied but with no results posted

  • Oxygen, light, temperature and manual therapies × fatigue and energy: 7 trials registered, none with results posted (1 still recruiting)
  • Supplements and nutraceuticals × fatigue and energy: 5 trials registered, none with results posted
  • Exercise and physical activity × fatigue and energy: 4 trials registered, none with results posted (1 still recruiting)
  • Rehabilitation and therapy services × fatigue and energy: 4 trials registered, none with results posted
  • Mind-body and psychological approaches × fatigue and energy: 4 trials registered, none with results posted
  • Mind-body and psychological approaches × physical function and exercise capacity: 4 trials registered, none with results posted (1 still recruiting)
  • Neuromodulation and electrical stimulation × fatigue and energy: 4 trials registered, none with results posted (1 still recruiting)
  • Rehabilitation and therapy services × physical function and exercise capacity: 3 trials registered, none with results posted (1 still recruiting)
  • Oxygen, light, temperature and manual therapies × symptom severity and disease activity: 3 trials registered, none with results posted (1 still recruiting)
  • Supplements and nutraceuticals × pain: 3 trials registered, none with results posted (1 still recruiting)

Design a trial with DecenTrial (beta) Fund a component of this work

A gap here means no matching trial was found among those searched, not that an approach would work. About one trial in six has primary outcomes the rules cannot classify, so a few gaps may be measured under another name. Some gaps are gaps for good reason.

Most-studied approaches for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome

Download this matrix (CSV) Non-drug evidence map Evidence brief RepurpOS condition page Condition page

How outcomes are grouped

Each trial's primary outcome measures are sorted into domains by keyword rules. 4 trials for this condition have primary outcomes the rules could not classify; they appear in the last column rather than being dropped. Checked against 90 hand-labelled outcomes; on a held-out sample of 30, the rules agreed with the hand label for 20 before adjustment, and every outcome they labelled was labelled correctly (misses were left unclassified).

Trial selection and exclusions follow the non-drug evidence map method. Source: ClinicalTrials.gov, searched 2026-11-16.